And despite the sales slump in the U.S. this past quarter, Pfizer’s Prevnar dynasty still leads in pediatric pneumococcal vaccination worldwide and among conjugated pneumococcal vaccines for adults in ...

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...

Pfizer on Tuesday raised its full-year profit forecast for the second quarter in a row as robust demand for its blockbuster ...

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a ...

Some Alberta pharmacists say they've started waitlists for private COVID-19 vaccines because they can't get their hands on ...

Pfizer raised its full-year profit forecast for the second consecutive quarter and reported a higher-than-expected ...

The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and ...

Pfizer has today lifted its full-year profit forecast for the second time in a row as robust demand for its blockbuster heart treatment and blood thinner helped it post third-quarter earnings above ...

Investing.com - Pfizer has raised and narrowed its full-year earnings outlook for a second consecutive quarter, after strong demand for its blood thinner medication helped fuel solid third-quarter ...

If you're an individual retail investor searching for healthcare stocks you can buy and hold for at least 20 years, here are ...

Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday as both companies submitted ...